Skip to content

Author

Hrithika Panday

We have 2 of 9 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Precision repurposing of clinically characterized molecules targeting dengue virus RNA-dependent RNA polymerase: an in silico identification and in vitro validation.

Proanthocyanidin is identified as a promising RdRp-targeting antiviral candidate and the value of integrating computational and experimental approaches for dengue drug discovery is demonstrated, demonstrating the value of integrating computational and experimental approaches for dengue drug discovery.

Hrithika Panday, Babita Bohra, R. Shukla et al. · 0 citations
Review Open access Aug 2026

mRNA Cancer Vaccines: A Critical Appraisal of Applications, Persistent Challenges and Realistic Future Perspectives

Analysis of the reported discrepancies indicates that heterogeneity in neoantigen prediction pipelines, assay thresholds for defining an immune response, and tumour microenvironmental context explain much of the apparent inconsistency between trials.

Prakash Bharti, Anshul Singh, Hrithika Panday et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.